Found: 12
Select item for more details and to access through your institution.
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34562-5
- By:
- Publication type:
- Article
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29655-0
- By:
- Publication type:
- Article
Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 449, doi. 10.1002/ajh.26809
- By:
- Publication type:
- Article
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture.
- Published in:
- Journal of Cell Biology, 2004, v. 165, n. 2, p. 263, doi. 10.1083/jcb.200309102
- By:
- Publication type:
- Article
Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: Modulation by inhibitors of PI3 kinase and MEK.
- Published in:
- Journal of Neuroscience Research, 2003, v. 73, n. 1, p. 105, doi. 10.1002/jnr.10632
- By:
- Publication type:
- Article
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in Melanoma.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2914, doi. 10.3390/cancers16162914
- By:
- Publication type:
- Article
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
- Published in:
- Nature, 2012, v. 487, n. 7408, p. 505, doi. 10.1038/nature11249
- By:
- Publication type:
- Article
Evaluation of statistical approaches for association testing in noisy drug screening data.
- Published in:
- BMC Bioinformatics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12859-022-04693-z
- By:
- Publication type:
- Article
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
- By:
- Publication type:
- Article
Reproducibility of Renal Length Measurements with <sup>99m</sup>Tc-DSMA SPECT.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 10, p. 1632
- By:
- Publication type:
- Article
Effect of Early Emptying on Quantitation and Interpretation of Liquid Gastric Emptying Studies of Infants and Young Children.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 4, p. 596
- By:
- Publication type:
- Article